Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

2001 • 5,189 citations

Induction of Chronic Myelogenous Leukemia in Mice by the P210 ^bcr/abl Gene of the Philadelphia Chromosome

1990 • 2,207 citations

Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor

2001 • 2,038 citations

The molecular biology of chronic myeloid leukemia

2000 • 1,596 citations

The Biology of Chronic Myeloid Leukemia

1999 • 1,308 citations

Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products

1990 • 1,305 citations

Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia

2000 • 897 citations

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

1977 • 888 citations

Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia

1994 • 592 citations

Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia

1997 • 565 citations

Clonal origin of chronic myelocytic leukemia in man.

1967 • 532 citations

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

1994 • 467 citations

UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

1995 • 409 citations

An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology

1999 • 389 citations

The Expression Pattern of the c-kit Ligand in Gonads of Mice Supports a Role for the c-kit Receptor in Oocyte Growth and in Proliferation of Spermatogonia

1993 • 303 citations

Chronic myelogenous leukemia in blast crisis

1987 • 283 citations

Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

1996 • 192 citations

A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase

1995 • 191 citations

The BCR gene and philadelphia chromosome-positive leukemogenesis.

2001 • 130 citations

Chronic myelogenous leukemia

2001 • 90 citations

Early Nonspecific Immune Responses and Immunity to Blood-Stage NonlethalPlasmodium yoeliiMalaria

2000 • 81 citations

Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.

1992 • 65 citations

Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia

1997 • 62 citations

Expression of Xkl-1, a Xenopus gene related to mammalian c-kit, in dorsal embryonic tissue

1995 • 22 citations